col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


187 Results       Page 1

 [1] 
Wiley: Allergy
  original article Date Title Authors   All Authors
1 [GO] 2023―Nov―15 Impact of COVID-19 on care-seeking patterns for hay fever in Japan: A retrospective claims database cohort study Yasutsugu Akasaki, Masao Iwagami, Jaemyoung Sung, Ken Nagino, Takeya Adachi, Hideaki Morita, et al. (+23)
2 [GO] 2023―Jul―21 The association between allergic rhinitis and the risk of coronavirus disease 2019 (COVID-19): A national survey in China Xiaozhe Yang, Jinming Zhao, Yutong Sima, Yan Zhao, Jing Zhang, Xiangdong Wang, Luo Zhang
3 [GO] 2023―Jul―20 Large cohort study shows increased risk of developing atopic dermatitis after COVID-19 disease Jochen Schmitt, Franz Ehm, Annika Vivirito, Danny Wende, Manuel Batram, Friedrich Loser, et al. (+17)
4 [GO] 2023―Jul―09 Disrupted epithelial permeability as a predictor of severe COVID-19 development Duygu Yazici, Eren Cagan, Ge Tan, Manru Li, Evan Do, Ozan C. Kucukkase, et al. (+14)
5 [GO] 2023―Jun―30 Value of vaccine and vaccine excipient skin testing to COVID-19 vaccines Knut Brockow, Rebekka Bent, Tilo Biedermann
6 [GO] 2023―Jun―26 Protein expression of SARS-CoV-2 receptors ACE2 and TMPRSS2 in allergic airways after allergen challenge Christiane E. Whetstone, Maral Ranjbar, Ruth P. Cusack, Dhuha Al-Sajee, Hafsa Omer, Nadia Alsaji, et al. (+11)
7 [GO] 2023―Apr―26 A Multicenter Time Series Study on Pollen Exposure and COVID-19 Infection in Five Cities in China Xiaozhe Yang, Jing Zha ng, Yutong Sima, Jinming Zhao, Xiangdong Wang, Luo Zhang
8 [GO] 2023―Mar―27 Risk stratification through extensive allergy work-up in COVID-19-mRNA vaccine allergic reactions Angèle Soria, Marina Labella, Inmaculada Doña, Pascale Nicaise-Roland, Sylvie Chollet-Martin, Jean-Eric Autegarden, et al. (+5)
9 [GO] 2023―Feb―01 Treatment of COVID -19 patients with a SARS-CoV -2-specific siRNA -peptide dendrimer formulation Musa Khaitov, Alexandra Nikonova, Ilya Kofiadi, Igor Shilovskiy, Valeriy Smirnov, Olga Elisytina, et al. (+32)
10 [GO] 2023―Jan―21 Sex-specific differences in immune response to SARS-CoV -2 vaccination vanish with age Daniel Brigger, Pascal Guntern, Hulda R. Jonsdottir, Luke F. Pennington, Benjamin Weber, Adriano Taddeo, et al. (+5)
11 [GO] 2023―Jan―11 Severe Cutaneous Adverse Reactions After COVID-19 Vaccination: A Systematic Review Po-Chien Wu, I-Hsin Huang, Chuang-Wei Wang, Wen-Hung Chung, Chun-Bing Chen
12 [GO] 2022―Nov―28 National trends in the prevalence of allergic diseases among Korean adolescents before and during COVID-19, 2009-2021: A serial analysis of the national representative study Min Ji Koo, Rosie Kwon, Seung Won Lee, Yong Sung Choi, Youn Ho Shin, Sang Youl Rhee, et al. (+13)
13 [GO] 2022―Nov―28 COVID -19 pandemic and environment: Not only air pollution Marco Caminati, Gabriella Guarnieri, Pierpaolo Marchetti, Fabiana Furci, Gianenrico Senna, Andrea Vianello, et al. (+4)
14 [GO] 2022―Nov―28 Reply to: “COVID-19 pandemic and environment: Not only air pollution.” Silvana Fiorito, Marzia Soligo, Yadong Gao, Ismail Ogulur, Cezmi A. Akdis, Sergio Bonini
15 [GO] 2022―Oct―01 The impact of dupilumab treatment on SARS-CoV-2 T cell responses in atopic dermatitis patients Benjamin Ungar, Susan Hartzell, Daniel Lozano-Ojalvo, Sabrina Ghalili, Swaroop Bose, Alexandra K. Golant, et al. (+6)
16 [GO] 2022―Sep―21 Implementation of the web-based calculator estimating odds ratio of severe COVID -19 for unvaccinated individuals in a country with high coronavirus-related death toll Miroslaw Kwasniewski, Urszula Korotko, Karolina Chwialkowska, Magdalena Niemira, Jerzy Jaroszewicz, Barbara Sobala-Szczygiel, et al. (+52)
17 [GO] 2022―Sep―01 New insights into human immune memory from SARS-CoV-2 infection and vaccination Gemma E. Hartley, Emily S. J. Edwards, Robyn E. O’Hehir, Menno C. van Zelm
18 [GO] 2022―Aug―06 Correspondence to “Differentiation of COVID-19 signs and symptoms from allergic rhinitis and common cold: An ARIA-EAACI-GA2LEN consensus” Peter K. Smith, Olivia Lesslar, David B. Price
19 [GO] 2022―Aug―06 Reply to correspondence to ‘Differentiation of COVID-19 signs and symptoms from allergic rhinitis and common cold: An ARIA-EAACI-GA2LEN consensus’ Jan Hagemann, Torsten Zuberbier, Giorgio Walter Canonica, Hubert Blain, Jean Bousquet, Ludger Klimek
20 [GO] 2022―Jul―24 SARS-CoV-2 infection in severe asthma is associated with worsening of COVID-19 through respiratory NLRP3 inflammasome activation Jae Seok Jeong, Jin Young Choi, Jong Seung Kim, Seong Ok Park, Wankyu Kim, Yeo-Gha Yoon, et al. (+7)
21 [GO] 2022―Jul―23 Exposure to avian coronavirus vaccines is associated with increased levels of SARS-CoV -2-cross-reactive antibodies Ozge Ardicli, K. Tayfun Carli, Pattraporn Satitsuksanoa, Anita Dreher, Alexia Cusini, Sandra Hutter, et al. (+11)
22 [GO] 2022―Jun―30 Reply to correspondence: Basophil reactivity to BNT162b2 in COVID-19 convalescence Marina Labella, Jose Antonio Céspedes, Inmaculada Doña, Mohamed H. Shamji, Ioana Agache, Cristobalina Mayorga, Maria José Torres
23 [GO] 2022―Jun―22 Presentation of airway and general symptoms in Covid-19 caused by dominant SARS-CoV-2 variants: a follow-up on ARIA consensus Jan Hagemann, Gabrielle Onorato, Christopher Seifen, Sven Becker, Tilman Huppertz, Heidi Olze, et al. (+46)
24 [GO] 2022―Jun―20 Management of suspected and confirmed COVID -19 ( SARS-CoV -2) vaccine hypersensitivity M. Worm, A. Alexiou, A. Bauer, R. Treudler, G. Wurpts, H. Dickel, et al. (+15)
25 [GO] 2022―Jun―12 Combined assessment of S- and N-specific IL -2 and IL -13 secretion and CD69 neo-expression for discrimination of post-infection and post-vaccination cellular SARS-CoV -2-specific immune response Bernhard Kratzer, Larissa C. Schlax, Pia Gattinger, Petra Waidhofer-Söllner, Doris Trapin, Peter A. Tauber, et al. (+16)
26 [GO] 2022―Jun―12 Immune-inflammatory proteome of elite ice hockey players before and after SARS-CoV-2 infection Debbie J. Maurer, Elena Barletta, Anja Heider, Nino Stocker, Alexandra Wallimann, Michael Villiger, et al. (+4)
27 [GO] 2022―May―14 Long-term effects of homologous and heterologous SARS-CoV -2 vaccination on humoral and cellular immune responses Moritz M. Hollstein, Lennart Münsterkötter, Michael P. Schön, Armin Bergmann, Thea M. Husar, Anna Abratis, et al. (+14)
28 [GO] 2022―May―02 COVID-19 in the absence of eosinophils: The outcome of confirmed SARS-CoV-2 infection whilst on treatment with benralizumab Charles HR Francis, Andrew P Hearn, Sharenja Ratnakumar, Alexander Taylor, Jordan Duckitt, Usmaan Ahmed, et al. (+3)
29 [GO] 2022―May―02 A potential immunological silver bullet for COVID-19: the trivalent chimpanzee adenoviral serotype-68 vector (Tri:ChAd) Ozge Ardicli, Ahmet Kursat Azkur, Dilek Azkur
30 [GO] 2022―Apr―19 Effect of BTN162b2 and Coronavac boosters on humoral and cellular immunity of individuals previously fully vaccinated with Coronavac against SARS-CoV-2: A longitudinal study Zeynep Ece Kuloğlu, Rojbin El, Gülen Guney-Esken, Yeşim Tok, Zeynep Gülçe Talay, Tayfun Barlas, et al. (+7)
31 [GO] 2022―Apr―11 Intranasal administration of a VLP-based vaccine induces neutralizing antibodies against SARS-CoV-2 and variants of concern Dominik A. Rothen, Pascal S. Krenger, Aleksandra Nonic, Ina Balke, Anne-Cathrine S. Vogt, Xinyue Chang, et al. (+9)
32 [GO] 2022―Apr―01 Autoantibodies in COVID-19 correlate with anti-viral humoral responses and distinct immune signatures Patrick Taeschler, Carlo Cervia, Yves Zurbuchen, Sara Hasler, Christian Pou, Ziyang Tan, et al. (+10)
33 [GO] 2022―Mar―31 Vaccine based on folded RBD-PreS fusion protein with potential to induce sterilizing immunity to SARS-CoV-2 variants Pia Gattinger, Bernhard Kratzer, Inna Tulaeva, Katarzyna Niespodziana, Anna Ohradanova-Repic, Laura Gebetsberger, et al. (+13)
34 [GO] 2022―Mar―30 Are health care policies for COVID-19 evidence-based? Sergio Bonini, Silvana Fiorito
35 [GO] 2022―Mar―29 Virus-related stimuli modulate SARS-CoV-2 entry factor expression in pediatric tonsillar epithelial cells in vitro Mariko Hara, Noriko Morimoto, Takahisa Watabe, Takeshi Inoue, Natsuki Takada, Yasunobu Amari, et al. (+2)
36 [GO] 2022―Mar―27 Mast Cells in Lung Damage of COVID-19 Autopsies: a descriptive study Tina Schaller, Bruno Märkl, Rainer Claus, Lynette Sholl, Jason L. Hornick, Matthew P. Giannetti, et al. (+3)
37 [GO] 2022―Mar―10 Do basophil activation tests help elucidate allergic reactions to the ingredients in COVID-19 vaccines? Bernadette Eberlein, Mathes Sonja, Jörg Fischer, Ulf Darsow, Tilo Biedermann, Knut Brockow
38 [GO] 2022―Mar―07 Humoral immune response of Sinopharm/BBIBP COVID-19 vaccination before and after the booster immunization Zhangkai J. Cheng, Huimin Huang, Peiyan Zheng, Mingshan Xue, Jing Ma, Zhiqing Zhan, et al. (+8)
39 [GO] 2022―Feb―25 Has the Spring 2020 lockdown modified the relationship between air pollution and COVID-19 mortality in Europe? Isabella Annesi-Maesano, Cara Nichole Maesano, Boris Dessimond, Julie Prud’homme, Augustin Colette, Soutrik Banerjee
40 [GO] 2022―Feb―21 Omicron: A SARS-CoV-2 variant of real concern Pia Gattinger, Inna Tulaeva, Kristina Borochova, Bernhard Kratzer, Doris Trapin, Anna Kropfmüller, et al. (+2)
41 [GO] 2022―Feb―17 Comparative assessment of allergic reactions to COVID-19 vaccines in Europe and the United States Sophia Hatziantoniou, Cleo Anastassopoulou, Vicky Lampropoulou, Helena C. Maltezou, Evangelos Andreakos, Gregory A. Poland, Athanasios Tsakris
42 [GO] 2022―Feb―17 Effects of non-steroidal anti-inflammatory drugs and other eicosanoid pathway modifiers on antiviral and allergic responses: EAACI task force on eicosanoids consensus report in times of COVID-19 Milena Sokolowska, G Enrico Rovati, Zuzana Diamant, Eva Untersmayr, Jürgen Schwarze, Zuzanna Lukasik, et al. (+11)
43 [GO] 2022―Feb―12 Metabolic Rewiring and Serotonin Depletion in Patients with Post-Acute Sequelae of COVID-19 Corinna Sadlier, Werner C. Albrich, Ujjwal Neogi, Nonhlanhla Lunjani, Mary Horgan, Paul W. O’Toole, Liam O’Mahony
44 [GO] 2022―Feb―11 COVID-19 vaccination in patients receiving allergen immunotherapy (AIT) or biologicals - EAACI recommendations Marek Jutel, Maria J. Torres, Oscar Palomares, Cezmi A Akdis, Thomas Eiwegger, Eva Untersmayr, et al. (+64)
45 [GO] 2022―Feb―06 Interdependencies of cellular and humoral immune responses in heterologous and homologous SARS-CoV-2 vaccination Moritz M. Hollstein, Lennart Münsterkötter, Michael P. Schön, Armin Bergmann, Thea M. Husar, Anna Abratis, et al. (+13)
46 [GO] 2022―Feb―03 Allergies and COVID-19 vaccines: An ENDA/EAACI Position paper Annick Barbaud, Lene Heise Garvey, Alessandra Arcolaci, Knut Brockow, Francesca Mori, Cristobalina Mayorga, et al. (+76)
47 [GO] 2022―Feb―01 Is epithelial barrier hypothesis the key to understanding the higher incidence and excess mortality during COVID-19 pandemic? - The case of Northern Italy Silvana Fiorito, Marzia Soligo, Yadong Gao, Ismail Ogulur, Cezmi A. Akdis, Sergio Bonini
48 [GO] 2022―Jan―12 Higher Levels of Bacterial DNA in Serum Associate with Severe and Fatal COVID-19 Nonhlanhla Lunjani, Werner C. Albrich, Noémie Suh, Beatrice Barda, Laura A. Finnegan, Sarita A. Dam, et al. (+5)
49 [GO] 2022―Jan―06 Serological testing for SARS-CoV-2 antibodies in clinical practice: a comparative diagnostic accuracy study Michael P. Horn, Hulda R. Jonsdottir, Daniel Brigger, Lauro Damonti, Franziska Suter-Riniker, Olga Endrich, et al. (+7)
50 [GO] 2021―Dec―29 Successful administration of second dose of BNT162b2 COVID-19 vaccine in two patients with potential anaphylaxis to first dose Julia A. Cahill, Manstein Kan
51 [GO] 2021―Nov―25 Mast cell activation is associated with post-acute COVID-19 syndrome Joshua B. Wechsler, Melina Butuci, Alan Wong, Amol P. Kamboj, Bradford A. Youngblood
52 [GO] 2021―Nov―25 Analysis of BNT162b2- and CVnCoV-elicited sera and of convalescent sera towards SARS-CoV-2 viruses Sascha Hein, Marie-Luise Herrlein, Ines Mhedhbi, Daniela Bender, Vanessa Haberger, Nuka Benz, et al. (+10)
53 [GO] 2021―Nov―24 The form of PEG matters: PEG conjugated with lipids and not PEG alone could be the specific form involved in allergic reactions to COVID-19 vaccines Beatriz Cabanillas, Natalija Novak, Cezmi A. Akdis
54 [GO] 2021―Nov―23 Childhood BCG vaccination seems to selectively protect adult males from COVID-19 infection Moritz K. Jansson, Kerstin Neuber, Heinrik Rudolf, Andreas Podbielski, J. Christian Virchow, Philipp Warnke
55 [GO] 2021―Nov―22 Experience with polyethylene glycol allergy-guided risk management for COVID-19 vaccine anaphylaxis Knut Brockow, Sonja Mathes, Jörg Fischer, Sebastian Volc, Ulf Darsow, Bernadette Eberlein, Tilo Biedermann
56 [GO] 2021―Nov―15 COVID-19 Vaccines Tolerated in Patients with Paclitaxel and Docetaxel Allergy Aleena Banerji, Anna R. Wolfson, Lacey B. Robinson, Aubree E. McMahon, Amelia S. Cogan, Rebecca R. Saff, Kimberly G. Blumenthal
57 [GO] 2021―Oct―26 Determinants of expression of SARS-CoV-2 entry related genes in upper and lower airways Hananeh Aliee, Florian Massip, Cancan Qi, Maria Stella de Biase, Jos van Nijnatten, Elin T.G. Kersten, et al. (+28)
58 [GO] 2021―Oct―24 The value of the basophil activation test in the evaluation of patients reporting allergic reactions to the BNT162b2 mRNA COVID-19 vaccine Marina Labella, Jose Antonio Céspedes, Inmaculada Doña, Mohamed H Shamji, Ioana Agache, Cristobalina Mayorga, Maria José Torres
59 [GO] 2021―Oct―18 RBD-IgG levels correlate with protection in residents facing SARS-CoV-2 B.1.1.7 Outbreaks Hubert Blain, Edouard Tuaillon, Lucie Gamon, Amandine Pisoni, Stéphanie Miot, Valentin Delpui, et al. (+11)
60 [GO] 2021―Oct―12 Persistence of infectious SARS-CoV-2 particles for up to 37 days in patients with mild COVID-19 Tobias Zahn, Ines Mhedhbi, Sascha Hein, Jan Raupach, Csaba Miskey, Younes Husria, et al. (+9)
61 [GO] 2021―Sep―28 What we know and still ignore on COVID-19 immune pathogenesis and a proposal based on experience of allergic disorders Enrico Maggi, Bruno Giuseppe Azzarone, Giorgio Walter Canonica, Lorenzo Moretta
62 [GO] 2021―Sep―20 COVID-19 vaccination with BNT162b2 and ChAdOx1 vaccines has the potential to induce nasal neutralizing antibodies Declercq Jozefien, Tobback Els, Stijn Vanhee, Natalie De Ruyck, Gerlo Sarah, Philippe Gevaert, Vandekerckhove Linos
63 [GO] 2021―Sep―14 Development and Preclinical Evaluation of Virus Like Particle Vaccine Against COVID-19 Infection Ismail Cem Yilmaz, Emre Mert Ipekoglu, Artun Bulbul, Nilsu Turay, Muzaffer Yildirim, Irem Evcili, et al. (+32)
64 [GO] 2021―Sep―08 A scalable and highly immunogenic virus-like particle-based vaccine against SARS-CoV-2 Mona O. Mohsen, Ina Balke, Simon Zinkhan, Villija Zeltina, Xuelan Liu, Xinyue Chang, et al. (+22)
65 [GO] 2021―Aug―28 In vitro data suggest that Indian variant B.1.617 of SARS-CoV-2 escapes neutralization by both receptor affinity and immune evasion Gilles Augusto, Mona O. Mohsen, Simon Zinkhan, Xuelan Liu, Monique Vogel, Martin F. Bachmann
66 [GO] 2021―Aug―28 Neutralization of SARS-CoV-2 requires antibodies against conformational receptor-binding domain epitopes Pia Gattinger, Katarzyna Niespodziana, Karin Stiasny, Sabina Sahanic, Inna Tulaeva, Kristina Borochova, et al. (+23)
67 [GO] 2021―Aug―14 Antiviral response in vernal keratoconjunctivitis may be protective against COVID-19 Andrea Leonardi, Umberto Rosani, Fabiano Cavarzeran, Philippe Daull, Jean-Sebastien Garrigue, Paola Brun
68 [GO] 2021―Aug―13 A single dose of BNT162b2 vaccine elicits strong humoral response in SARS-CoV-2 seropositive individuals Teodora Brnjarchevska Blazhevska, Haris Babačić, Olgica Sibinovska, Boban Dobrevski, Meri Kirijas, Gorjan Milanovski, et al. (+2)
69 [GO] 2021―Aug―10 Inhaled Corticosteroids in early COVID-19 - a tale of many facets Ludger Klimek, Cezmi A. Akdis, Marek Jutel, Torsten Zuberbier, Jean Bousquet
70 [GO] 2021―Aug―09 Safe administration of the Pfizer-BioNtTech COVID-19 vaccine following an immediate reaction to the first dose Aharon Kessel, Ellen Bamberger, Liat Nachshon, Yossi Rosman, Ronit Confino-Cohen, Arnon Elizur
71 [GO] 2021―Jul―27 Adverse COVID-19 Outcomes in Immune Deficiencies; Inequality Exists Between Subclasses Elif Karakoc Aydiner, Sevgi Bilgic Eltan, Royale Babayeva, Omer Aydiner, Eda Kepenekli, Burcu Kolukisa, et al. (+15)
72 [GO] 2021―Jul―10 A bird's eye view on the role of dendritic cells in SARS-CoV-2 infection: perspectives for immune-based vaccines Domenico Galati, Serena Zanotta, Ludovica Capitelli, Marialuisa Bocchino
73 [GO] 2021―Jul―09 Molecular definition of SARS-CoV-2 RBD mutations: receptor affinity versus neutralization of receptor interaction Monique Vogel, Gilles Sousa Augusto, Xinyue Chang, Xuelan Liu, Daniel Speiser, Mona O. Mohsen, Martin F. Bachmann
74 [GO] 2021―Jul―01 COVID-19 vaccines - the way forward Ludger Klimek, Ioana Agache, Emer Cooke, Marek Jutel, Cezmi A. Akdis, Robyn O'Hehir
75 [GO] 2021―Jun―28 One Health: EAACI Position Paper on coronaviruses at the human-animal interface, with a specific focus on comparative and zoonotic aspects of SARS-Cov-2 Anna D. J. Korath, Jozef Janda, Eva Untersmayr, Milena Sokolowska, Wojciech Feleszko, Ioana Agache, et al. (+4)
76 [GO] 2021―Jun―22 Cutaneous and systemic hyperinflammation drives maculopapular drug exanthema in severely ill COVID-19 patients Yasutaka Mitamura, Daniel Schulz, Saskia Oro, Nick Li, Isabel Kolm, Claudia Lang, et al. (+13)
77 [GO] 2021―Jun―18 Sweet syndrome induced by SARS-CoV-2 Pfizer-BioNTech mRNA vaccine AS Darrigade, H Théophile, P Sanchez-Pena, B Milpied, M Colbert, S Pedeboscq, et al. (+3)
78 [GO] 2021―Jun―15 Delayed local reactions after the first administration of the ChAdOx1 nCoV-19 vaccine Eunyong Shin, Seongman Bae, Jiwon Jung, Woo-Jung Song, Hyouk-Soo Kwon, Hee-Sung Kim, et al. (+4)
79 [GO] 2021―Jun―15 COVID-19 vaccine anaphylaxis: IgE, complement or what else? A reply to: “COVID-19 vaccine anaphylaxis: PEG or not?” Beatriz Cabanillas, Cezmi A. Akdis, Natalija Novak
80 [GO] 2021―Jun―15 COVID-19 vaccine anaphylaxis: PEG or not? Matthew S. Krantz, Yiwei Liu, Elizabeth J. Phillips, Cosby A. Stone
81 [GO] 2021―Jun―15 Other excipients than PEG might cause serious hypersensitivity reactions in COVID-19 vaccines Sander D. Borgsteede, Tjerk H. Geersing, Žana Tempels-Pavlica
82 [GO] 2021―Jun―15 COVID-19 vaccines and the role of other potential allergenic components different from PEG. A reply to: “Other excipients than PEG might cause serious hypersensitivity reactions in COVID-19 vaccines” Beatriz Cabanillas, Cezmi A. Akdis, Natalija Novak
83 [GO] 2021―Jun―04 Asthma phenotypes, associated comorbidities, and long-term symptoms in COVID-19 Lauren E. Eggert, Ziyuan He, William Collins, Alexandra S. Lee, Gopal Dhondalay, Shirley Y. Jiang, et al. (+15)
84 [GO] 2021―May―28 Adding the variable of environmental complexity into the COVID-19 pandemic equation Athanasios Damialis, Stefanie Gilles, Claudia Traidl-Hoffmann
85 [GO] 2021―May―24 Anaphylaxis to the first dose of mRNA SARS-CoV-2 vaccines: don’t give up on the second dose! Matthew S. Krantz, Maria A. Bruusgaard-Mouritsen, Grace Koo, Elizabeth J. Phillips, Cosby A. Stone, Lene H. Garvey
86 [GO] 2021―May―24 Long Term Disruption of Cytokine Signalling Networks are Evident in Patients that Required Hospitalisation for SARS-CoV-2 Infection Sinead Ahearn-Ford, Nonhlanhla Lunjani, Brian McSharry, John MacSharry, Liam Fanning, Gerard Murphy, et al. (+12)
87 [GO] 2021―May―14 ACE2 downregulation in olfactory mucosa: eosinophilic rhinosinusitis as COVID-19 protective factor? Concepció Marin, Valeria Tubita, Cristóbal Langdon, Mireya Fuentes, María Jesús Rojas-Lechuga, Antonio Valero, et al. (+2)
88 [GO] 2021―May―05 BNT162b2 mRNA COVID-19 vaccine induces antibodies of broader cross-reactivity than natural infection but recognition of mutant viruses is up to 10-fold reduced Xinyue Chang, Gilles Sousa Augusto, Xuelan Liu, Thomas M Kündig, Monique Vogel, Mona O. Mohsen, Martin F. Bachmann
89 [GO] 2021―May―05 Asia-Pacific Perspectives on the COVID-19 Pandemic Ruby Pawankar, Bernard Yu-Hor Thong, Marysia Tiongco-Recto, Jiu-Yao Wang, Amir Hamzah Abdul Latiff, Francis Thien, et al. (+10)
90 [GO] 2021―Apr―27 Anaphylaxis in The Emergency Department Unit: Before and during COVID-19 Leyla Pur Ozyigit, Ghayyur Khalil, Taimour Choudhry, Mark Williams, Nasreen Khan
91 [GO] 2021―Apr―27 Adherence to subcutaneous immunotherapy with aeroallergens in real-life practice during the COVID-19 pandemic Osman Ozan Yeğit, Semra Demir, Derya Ünal, Müge Olgaç, Kadriye Terzioğlu, Deniz Eyice, et al. (+5)
92 [GO] 2021―Apr―22 Profound dysregulation of T cell homeostasisand function in patients with severe COVID-19 Sarah Adamo, Stéphane Chevrier, Carlo Cervia, Yves Zurbuchen, Miro E. Raeber, Liliane Yang, et al. (+10)
93 [GO] 2021―Apr―22 Regulatory concepts to guide and promote the accelerated but safe clinical development and licensure of COVID-19 vaccines in Europe Ralf Wagner, Juliane Meißner, Elena Grabski, Yuansheng Sun, Stefan Vieths, Eberhard Hildt
94 [GO] 2021―Apr―10 Silencing of SARS-CoV-2 with modified siRNA-peptide dendrimer formulation Musa Khaitov, Alexandra Nikonova, Igor Shilovskiy, Ksenia Kozhikhova, Ilya Kofiadi, Lyudmila Vishnyakova, et al. (+26)
95 [GO] 2021―Apr―03 Vaccines and Allergic reactions: the past, the current COVID-19 pandemic, and future perspectives Vanitha Sampath, Grace Rabinowitz, Mihir Shah, Surabhi Jain, Zuzana Diamant, Milos Jesenak, et al. (+27)
96 [GO] 2021―Apr―03 Management of anaphylaxis due to COVID-19 vaccines in the elderly Jean Bousquet, Ioana Agache, Hubert Blain, Marek Jutel, Maria Teresa Ventura, Margitta Worm, et al. (+143)
97 [GO] 2021―Apr―03 Skin tests in urticaria/angioedema and flushing to Pfizer-BioNTech SARS-CoV-2 vaccine: limits of intradermal testing Leonardo Bianchi, Filippo Biondi, Katharina Hansel, Nicola Murgia, Marta Tramontana, Luca Stingeni
98 [GO] 2021―Mar―27 Real-life impact of COVID-19 pandemic lockdown on the management of pediatric and adult asthma: a survey by the EAACI Asthma Section Ibon Eguiluz-Gracia, Maarten van den Berge, Cristina Boccabella, Matteo Bonini, Cristiano Caruso, Mariana Couto, et al. (+6)
99 [GO] 2021―Mar―25 Detection of SARS-CoV-2 Specific Memory B cells to Delineate Long-Term COVID-19 Immunity Constantin J. Thieme, Mohamed Abou-el-Enein, Enrico Fritsche, Moritz Anft, Krystallenia Paniskaki, Sarah Skrzypczyk, et al. (+14)
100 [GO] 2021―Mar―18 Pros and cons for the role of air pollution on COVID-19 development Isabella Annesi-Maesano, Cara Nichole Maesano, Maria D’Amato, Gennaro D’Amato
101 [GO] 2021―Mar―17 Differentiation of COVID-19 signs and symptoms from allergic rhinitis and common cold- An ARIA-EAACI-GA 2 LENconsensus Jan Hagemann, Gabrielle L. Onorato, Marek Jutel, Cezmi A Akdis, Ioana Agache, Torsten Zuberbier, et al. (+94)
102 [GO] 2021―Mar―06 Cabbage and COVID-19 Joan B. Soriano, Julio Ancochea
103 [GO] 2021―Mar―06 Reply to “Cabbage and COVID-19” Josep M. Anto, Jean Bousquet
104 [GO] 2021―Mar―06 Asthmatic patients and COVID-19: Different disease course? Ricardo Wesley Alberca, Tatiana Yendo, Valéria Aoki, Maria Notomi Sato
105 [GO] 2021―Mar―06 Reply to: Kow CS et al. Are severe asthma patients at higher risk of developing severe outcomes from COVID-19? Enrico Heffler, Aikaterini Detoraki, Marco Contoli, Alberto Papi, Giovanni Paoletti, Giacomo Malipiero, et al. (+11)
106 [GO] 2021―Mar―04 Allergenic components of the mRNA-1273 vaccine for COVID-19: possible involvement of polyethylene glycol and IgG-mediated complement activation Ludger Klimek, Natalija Novak, Beatriz Cabanillas, Marek Jutel, Jean Bousquet, Cezmi A. Akdis
107 [GO] 2021―Mar―03 COVID-19 pandemic and allergen immunotherapy - an EAACI survey Oliver Pfaar, Ioana Agache, Matteo Bonini, Helen Annaruth Brough, Tomás Chivato, Stefano R. Del Giacco, et al. (+26)
108 [GO] 2021―Mar―02 Impact of anxiety, stress and depression related to COVID-19 pandemic on the course of hereditary angioedema with C1 inhibitor deficiency Deniz Eyice Karabacak, Semra Demir, Osman Ozan Yeğit, Ali Can, Kadriye Terzioğlu, Derya Erdoğdu Ünal, et al. (+5)
109 [GO] 2021―Feb―21 Childhood asthma outcomes during the COVID-19 pandemic: Findings from the PeARL multi-national cohort Nikolaos G. Papadopoulos, Alexander G. Mathioudakis, Adnan Custovic, Antoine Deschildre, Wanda Phipatanakul, Gary Wong, et al. (+36)
110 [GO] 2021―Feb―14 Management of patients with atopic dermatitis undergoing systemic therapy during COVID-19 pandemic in Italy: data from the DA-COVID-19 registry Andrea Chiricozzi, Marina Talamonti, Clara De Simone, Marco Galluzzo, Niccolò Gori, Gabriella Fabbrocini, et al. (+65)
111 [GO] 2021―Jan―23 Elastase and Exacerbation of Neutrophil Innate Immunity are Involved in Multi-Visceral Manifestations of COVID-19 Jean-Louis Guéant, Rosa-Maria Guéant-Rodriguez, Julien Fromonot, Abderrahim Oussalah, Huguette Louis, Celine Chery, et al. (+8)
112 [GO] 2021―Jan―16 EAACI statement on the diagnosis, management and prevention of severe allergic reactions to COVID-19 vaccines Milena Sokolowska, Thomas Eiwegger, Markus Ollert, Maria J Torres, Domingo Barber, Stefano Del Giacco, et al. (+8)
113 [GO] 2021―Jan―15 Allergic reactions to COVID-19 -vaccinations - unveiling the secret(s) O Pfaar, V Mahler
114 [GO] 2021―Jan―11 Association of endopeptidases, involved in SARS-CoV-2 infection, with microbial aggravation in sputum of severe asthma Mahmoud I. Abdel-Aziz, Nazanin Zounemat Kermani, Anne H. Neerincx, Susanne J.H. Vijverberg, Yike Guo, Peter Howarth, et al. (+7)
115 [GO] 2020―Dec―31 Genetic predisposition to allergic diseases is inversely associated with risk of COVID-19 Susanna C. Larsson, Dipender Gill
116 [GO] 2020―Dec―31 ARIA-EAACI statement on severe allergic reactions to COVID-19 vaccines - an EAACI-ARIA position paper Ludger Klimek, Marek Jutel, Cezmi A. Akdis, Jean Bousquet, Mübeccel Akdis, Maria Torres-Jaen, et al. (+11)
117 [GO] 2020―Dec―20 Allergic reactions to the first COVID-19 vaccine: a potential role of Polyethylene glycol? Beatriz Cabanillas, Cezmi Akdis, Natalija Novak
118 [GO] 2020―Dec―19 SARS-CoV-2 candidate vaccines - composition, mechanisms of action and stages of clinical development Juan Rodriguez Coira, Milena Sokolowska
119 [GO] 2020―Dec―15 The role of circulating eosinophils on COVID-19 mortality varies by race/ethnicity Jacob W. Glickman, Ana B. Pavel, Emma Guttman-Yassky, Rachel L. Miller
120 [GO] 2020―Dec―12 Multidisciplinary consensus on sputum induction biosafety during the COVID-19 pandemic Astrid Crespo-Lessmann, Vicente Plaza, Carlos Almonacid, María Luisa Caballero Soto, José Antonio Cañas, José Ángel Carretero Gracia, et al. (+16)
121 [GO] 2020―Dec―07 The global impact of the COVID-19 pandemic on the management and course of chronic urticaria Emek Kocatürk, Andaç Salman, Ivan Cherrez-Ojeda, Paulo Ricardo Criado, Jonny Peter, Elif Comert-Ozer, et al. (+92)
122 [GO] 2020―Nov―29 Association between asthma and clinical mortality/morbidity in COVID-19 patients using clinical epidemiologic data from Korean Disease Control & Prevention Hyo-Geun Choi, Jee Hye Wee, So Young Kim, Joo-Hee Kim, Hwan Il Kim, Ji-Young Park, et al. (+4)
123 [GO] 2020―Nov―19 Distinct expression of SARS-CoV-2 receptor ACE2 correlates with endotypes of chronic rhinosinusitis with nasal polyps Ming Wang, Xiangting Bu, Gaoli Fang, Ge Luan, Yanran Huang, Cezmi A. Akdis, et al. (+2)
124 [GO] 2020―Nov―13 Risk factors for severe and critically ill COVID-19 patients: a review Ya-dong Gao, Mei Ding, Xiang Dong, Jin-jin Zhang, Ahmet Kursat Azkur, Dilek Azkur, et al. (+14)
125 [GO] 2020―Oct―31 Immunological imprint of COVID-19 on human peripheral blood leukocyte populations Bernhard Kratzer, Doris Trapin, Paul Ettel, Ulrike Körmoczi, Arno Rottal, Friedrich Tuppy, et al. (+17)
126 [GO] 2020―Oct―23 Comment on: Bilò MB, Pravettoni V, Mauro M, Bonadonna P. Treating venom allergy during COVID-19 pandemic. Allergy. 2020 Jul 16. doi: 10.1111/all.14473 Emilia Martínez-Lourido, Andrea Otero, Margarita Armisén, Carmen Vidal
127 [GO] 2020―Oct―19 Management of patients with chronic rhinosinusitis during the COVID-19 pandemic - An EAACI Position Paper L. Klimek, M. Jutel, J. Bousquet, I. Agache, C. Akdis, V. Hox, et al. (+16)
128 [GO] 2020―Oct―11 Antibody dynamics to SARS-CoV-2 in asymptomatic COVID-19 infections Qing Lei, Yang Li, Hong-yan Hou, Feng Wang, Zhu-qing Ouyang, Yandi Zhang, et al. (+19)
129 [GO] 2020―Oct―04 Characterization of asthma and risk factors for delayed SARS-CoV-2 clearance in adult COVID-19 inpatients in Daegu Sujeong Kim, Chang-Gyu Jung, Ji Yeon Lee, Gunwoo Kim, Sae Won Choi, Hyun Jung Jin, Han-Ki Park
130 [GO] 2020―Oct―02 Are severe asthma patients at higher risk of developing severe outcomes from COVID-19? Chia Siang Kow, Toby Capstick, Syed Shahzad Hasan
131 [GO] 2020―Sep―30 Accuracy of serological testing for SARS-CoV-2 antibodies: first results of a large mixed-method evaluation study D. Brigger, M.P. Horn, L.F. Pennington, A.E. Powell, D. Siegrist, B. Weber, et al. (+18)
132 [GO] 2020―Sep―23 Small Droplet Emission in Exhaled Breath During Different Breathing Manoeuvres: Implications for Clinical Lung Function Testing during COVID-19 Neil J. Greening, Per Larsson, Evert Ljungström, Salman Siddiqui, Anna-Carin Olin
133 [GO] 2020―Sep―21 Dexamethasone, pro-resolving lipid mediators and resolution of inflammation in COVID-19 Evangelos Andreakos, Maria Papadaki, Charles N. Serhan
134 [GO] 2020―Sep―18 Asthma control, self-management and healthcare access during the COVID-19 epidemic in Beijing Chun Chang, Linlin Zhang, Fawu Dong, Ying Liang, Yahong Chen, Ying Shang, et al. (+2)
135 [GO] 2020―Sep―10 Thirty-six COVID-19 cases preventively vaccinated with mumps-measles-rubella vaccine: all mild course Désirée E. Larenas-Linnemann, Fernanda Rodríguez-Monroy
136 [GO] 2020―Sep―02 ACE2 expression and its implication in the association between COVID-19 and allergic rhinitis Hai Wang, Jia Song, Yin Yao, Yi- Deng, Zhi-Chao Wang, Bo Liao, et al. (+7)
137 [GO] 2020―Aug―28 Atopic statusprotects from severe complications of COVID-19 Enrico Scala, Damiano Abeni, Alberto Tedeschi, Giuseppina Manzotti, Baoran Yang, Paolo Borrelli, et al. (+5)
138 [GO] 2020―Aug―24 Asthma phenotypes, comorbidities, and disease activity in COVID-19: The need of risk stratification. Reply to Morais-Almeida Giulia Carli, Lorenzo Cecchi, Justin Stebbing, Paola Parronchi, Alessandro Farsi
139 [GO] 2020―Aug―14 “Severe asthma in adults does not significantly affect the outcome of COVID-19 disease: results from the Italian Severe Asthma Registry” Leonardo Antonicelli, Chiara Tontini, Giuseppina Manzotti, Luca Ronchi, Adriano Vaghi, Francesco Bini, et al. (+6)
140 [GO] 2020―Aug―07 Cabbage and fermented vegetables: from death rate heterogeneity in countries to candidates for mitigation strategies of severe COVID-19 Jean Bousquet, Josep M Anto, Wienczyslawa Czarlewski, Tari Haahtela, Susana C Fonseca, Guido Iaccarino, et al. (+649)
141 [GO] 2020―Aug―07 Dupilumab, Severe Asthma Airway Responses, and SARS-CoV2 Serology Anurag Bhalla, Manali Mukherjee, Katherine Radford, Ishac Nazy, Melanie Kjarsgaard, Dawn M.E. Bowdish, Parameswaran Nair
142 [GO] 2020―Aug―05 Delayed virus-specific antibody responses associate with COVID-19 mortality Feng Wang, Yin Yao, Hongyan Hou, Shiji Wu, Cuilian Guo, Hongmin Zhou, et al. (+2)
143 [GO] 2020―Aug―05 Cross-sectional pilot study exploring the feasibility of a rapid SARS-CoV-2 immunization test in health and non-healthcare workers María M Escribese, Estanislao Nistal-Villan, Paloma Fernandez, Pilar Rico, Isabel A Martin-Antoniano, Alicia de la Cuerda, et al. (+2)
144 [GO] 2020―Aug―03 Blood Myeloperoxidase-DNA, a biomarker of early response to SARS-CoV-2 infection? Jean-Louis Guéant, Julien Fromonot, Rosa-Maria Guéant-Rodriguez, Patrick Lacolley, Régis Guieu, Véronique Regnault
145 [GO] 2020―Aug―01 COVID-19 in Severe Asthma Network in Italy (SANI) patients: clinical features, impact of comorbidities and treatments Enrico Heffler, Aikaterini Detoraki, Marco Contoli, Alberto Papi, Giovanni Paoletti, Giacomo Malipiero, et al. (+11)
146 [GO] 2020―Jul―31 Antibodies in serum of convalescent patients following mild COVID-19 do not always prevent virus receptor binding Pia Gattinger, Kristina Borochova, Yulia Dorofeeva, Rainer Henning, Renata Kiss, Bernhard Kratzer, et al. (+8)
147 [GO] 2020―Jul―29 BCG vaccination and socioeconomic variables vs COVID-19 global features: clearing up a controversial issue Luigi Ventura, Matteo Vitali, Vincenzo Romano Spica
148 [GO] 2020―Jul―29 SARS-CoV-2 receptorACE2 protein expression in serum is significantly associated with age Ana B. Pavel, Jianni Wu, Yael Renert-Yuval, Ester Del Duca, Jacob W. Glickman, Rachel L. Miller, et al. (+3)
149 [GO] 2020―Jul―27 Distinct effects of asthma and COPD comorbidity on disease expression and outcome in patients with COVID-19 Jia Song, Ming Zeng, Hai Wang, Chuan Qin, Hong-Yan Hou, Zi-Yong Sun, et al. (+13)
150 [GO] 2020―Jul―27 COVID-19 in severe asthmatic patients during ongoing treatment with biologicals targeting type 2 inflammation: results from a multicenter Italian survey A Matucci, M Caminati, V Vivarelli, A Vianello, C Micheletto, F Menzella, et al. (+14)
151 [GO] 2020―Jul―17 Treating venom allergy during COVID-19 pandemic Maria Beatrice Bilò, Valerio Pravettoni, Marina Mauro, Patrizia Bonadonna
152 [GO] 2020―Jul―14 Clinical, radiological and laboratory characteristics and risk factors for severity and mortality of 289 hospitalized COVID-19 patients Jin-jin Zhang, Yi-yuan Cao, Ge Tan, Xiang Dong, Bin-chen Wang, Jun Lin, et al. (+5)
153 [GO] 2020―Jul―13 SARS-CoV-2, COVID-19, skin and immunology - what do we know so far? N Novak, WM Peng, MC Naegeli, C Galvan, I Kolm-Djamei, MC Brüggen, et al. (+3)
154 [GO] 2020―Jul―08 Update on asthma prevalence in severe COVID-19 patients Mário Morais-Almeida, Miguel T. Barbosa, Cláudia S. Sousa, Rita Aguiar, Jean Bousquet
155 [GO] 2020―Jul―04 COVID-19 and Asthma, the Good or the Bad? Jiu-Yao Wang, Ruby Pawankar, Hui-Ju Tsai, Shih-Hsin Lawrence Wu, Wen-Shuo Kuo
156 [GO] 2020―Jun―27 ARIA-EAACI statement on Asthma and COVID-19 (June 2, 2020) Jean Bousquet, Marek Jutel, Cezmi A Akdis, Ludger Klimek, Oliver Pfaar, Kari C Nadeau, et al. (+114)
157 [GO] 2020―Jun―27 COVID-19: A series of important recent clinical and laboratory reports in immunology and pathogenesis of SARS-CoV-2 infection and care of allergy patients Oliver Pfaar, Maria J. Torres, Cezmi A. Akdis
158 [GO] 2020―Jun―25 Immunology of COVID-19: mechanisms, clinical outcome, diagnostics and perspectives - a report of the European Academy of Allergy and Clinical Immunology (EAACI) M Sokolowska, Z Lukasik, I Agache, CA Akdis, D Akdis, M Akdis, et al. (+31)
159 [GO] 2020―Jun―24 Could Anti-Tubercular Vaccination Protect Against Covid-19 Infection? Vincenzo Patella, Giovanni Florio, Brancaccio Raffaele, Gabriele Delfino
160 [GO] 2020―Jun―22 Telemedicine allows quantitative measuring of olfactory dysfunction in COVID-19 Ludger Klimek, Jan Hagemann, Ali Alali, Magdalena Spielhaupter, Tilman Huppertz, Karl Hörmann, et al. (+3)
161 [GO] 2020―Jun―20 The role of peripheral blood eosinophil counts in COVID-19 patients Guogang Xie, Fengming Ding, Lei Han, Dongning Yin, Hongzhou Lu, Min Zhang
162 [GO] 2020―Jun―16 COVID-19 in a patient with severe asthma treated with Omalizumab Marek Lommatzsch, Paul Stoll, J. Christian Virchow
163 [GO] 2020―Jun―16 Eosinopenia is associated with greater severity in patients with coronavirus disease 2019 Lei Zhao, Ye-ping Zhang, Xinchun Yang, Xin Liu
164 [GO] 2020―Jun―14 A compendium answering 150 questions on COVID-19 and SARS-CoV-2 Carmen Riggioni, Pasquale Comberiati, Mattia Giovannini, Ioana Agache, Mübeccel Akdis, Magna Alves-Correia, et al. (+36)
165 [GO] 2020―Jun―12 COVID-19 pandemic: Practical considerations on the organization of an allergy clinic - an EAACI/ARIA Position Paper O Pfaar, L Klimek, M Jutel, CA Akdis, J Bousquet, H Breiteneder, et al. (+71)
166 [GO] 2020―Jun―11 Clinical characteristics of 182 pediatric COVID-19 patients with different severities and allergic status Hui Du, Xiang Dong, Jin-jin Zhang, Yi-yuan Cao, M뻌el Akdis, Pei-qi Huang, et al. (+6)
167 [GO] 2020―Jun―08 Diagnosis and management of the drug hypersensitivity reactions in Coronavirus disease 19 Aslı Gelincik, Knut Brockow, Gülfem E Çelik, Inmaculada Doña, Lina Mayorga, Antonino Romano, et al. (+4)
168 [GO] 2020―Jun―07 Clinical characteristics of COVID-19 patients combined with allergy Wendan Shi, Ziang Gao, Yongjun Ding, Ting Zhu, Wei Zhang, Yu Xu
169 [GO] 2020―Jun―05 Considerations on Biologicals for Patients with allergic disease in times of the COVID-19 pandemic: an EAACI Statement Alessandra Vultaggio, Ioana Agache, Cezmi A. Akdis, M뻌el Akdis, Sevim Bavbek, Apostolos Bossios, et al. (+19)
170 [GO] 2020―Jun―04 Distribution of ACE2, CD147, CD26 and other SARS-CoV-2 associated molecules in tissues and immune cells in health and in asthma, COPD, obesity, hypertension, and COVID-19 risk factors U. Radzikowska, M. Ding, G. Tan, D. Zhakparov, Y. Peng, P. Wawrzyniak, et al. (+12)
171 [GO] 2020―Jun―01 Is asthma protective against COVID-19? G. Carli, L. Cecchi, J. Stebbing, P. Parronchi, A. Farsi
172 [GO] 2020―May―26 Low prevalence of bronchial asthma and chronic obstructive lung disease among intensive care unit patients with COVID-19 Sergey Avdeev, Sergey Moiseev, Michail Brovko, Andrey Yavorovskiy, Karina Umbetova, Larisa Akulkina, et al. (+4)
173 [GO] 2020―May―20 COVID-19Clinical trials: quality matters more than quantity Sergio Bonini, Giuseppe Maltese
174 [GO] 2020―May―13 Managing ocular allergy in the time of COVID-19 A Leonardi, JL Fauquert, S Doan, L Delgado, N Andant, L Klimek, B Bozkurt
175 [GO] 2020―May―13 SARS-CoV-2 immunogenicity at the crossroads Fariba Karamloo, Renate König
176 [GO] 2020―May―12 Immune response to SARS-CoV-2 and mechanisms of immunopathological changes in COVID-19 Ahmet Kursat Azkur, Mübeccel Akdis, Dilek Azkur, Milena Sokolowska, Willem van de Veen, Marie-Charlotte Brüggen, et al. (+4)
177 [GO] 2020―May―05 COVID-19, chronic inflammatory respiratory diseases and eosinophils - Observationsfrom reported clinical case series Milos Jesenak, Peter Banovcin, Zuzana Diamant
178 [GO] 2020―May―02 Asthma and COVID-19: is asthma a risk factor for severe outcomes? Sebastian L. Johnston
179 [GO] 2020―Apr―27 Is global BCG vaccination-induced trained immunity relevant to the progression of SARS-CoV-2 pandemic? Mayda Gursel, Ihsan Gursel
180 [GO] 2020―Apr―24 Handling of allergen immunotherapy in the COVID-19 pandemic: An ARIA-EAACI statement Ludger Klimek, Marek Jutel, Cezmi Akdis, Jean Bousquet, Mübeccel Akdis, Claus Bachert, et al. (+256)
181 [GO] 2020―Apr―24 Is BCG vaccination effecting the spread and severity of COVID-19? Cevdet Ozdemir, Umut C. Kucuksezer, Zeynep Ulker Tamay
182 [GO] 2020―Apr―19 Advanced forecasting of SARS-CoV-2 related deaths in Italy, Germany, Spain, and New York State Giovanni Sotgiu, Giovanni A. Gerli, Stefano Centanni, Monica Miozzo, G. Walter Canonica, Joan B. Soriano, Christian Virchow
183 [GO] 2020―Apr―13 Distinct characteristics of COVID-19 patients with initial rRT-PCR positive and negative results for SARS-CoV-2 Jin-jin Zhang, Yi-yuan Cao, Xiang Dong, Bin-chen Wang, Mei-yan Liao, Jun Lin, et al. (+3)
184 [GO] 2020―Apr―02 COVID-19 in a Designated Infectious Diseases Hospital Outside Hubei Province, China Qingxian Cai, Deliang Huang, Pengcheng Ou, Hong Yu, Zhibin Zhu, Zhang Xia, et al. (+8)
185 [GO] 2020―Mar―31 Intranasal corticosteroids in allergic rhinitis in COVID-19 infected patients: An ARIA-EAACI statement Jean Bousquet, Cezmi Akdis, Marek Jutel, Claus Bachert, Ludger Klimek, Ioana Agache, et al. (+33)
186 [GO] 2020―Mar―20 Eleven Faces of Coronavirus Disease 2019 Xiang Dong, Yi-yuan Cao, Xiao-xia Lu, Jin-jin Zhang, Hui Du, You-qin Yan, et al. (+2)
187 [GO] 2020―Feb―20 Clinical characteristics of 140 patients infected by SARS-CoV-2 in Wuhan, China Jin-jin Zhang, Xiang Dong, Yi-Yuan Cao, Ya-dong Yuan, Yi-bin Yang, You-qin Yan, et al. (+2)
 [1] 

187 Results       Page 1


[de][en]

Last change 2023―Oct―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.017 sec